| Silencing of microRNA‐21 in vivo ameliorates autoimmune splenomegaly in lupus mice BG Garchow, O Bartulos Encinas, YT Leung, PY Tsao, RA Eisenberg, ... EMBO molecular medicine 3 (10), 605-615, 2011 | 204 | 2011 |
| Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells X Ge, Y Ren, O Bartulos, MY Lee, Z Yue, KY Kim, W Li, PJ Amos, ... Circulation 126 (14), 1695-1704, 2012 | 132 | 2012 |
| Tissue-engineered vascular rings from human iPSC-derived smooth muscle cells BC Dash, K Levi, J Schwan, J Luo, O Bartulos, H Wu, C Qiu, T Yi, Y Ren, ... Stem Cell Reports 7 (1), 19-28, 2016 | 97 | 2016 |
| Anisotropic engineered heart tissue made from laser-cut decellularized myocardium J Schwan, AT Kwaczala, TJ Ryan, O Bartulos, Y Ren, LR Sewanan, ... Scientific reports 6 (1), 32068, 2016 | 93 | 2016 |
| Vascular smooth muscle cells derived from inbred swine induced pluripotent stem cells for vascular tissue engineering J Luo, L Qin, MH Kural, J Schwan, X Li, O Bartulos, X Cong, Y Ren, L Gui, ... Biomaterials 147, 116-132, 2017 | 40 | 2017 |
| Functional cardiomyocytes derived from Isl1 cardiac progenitors via Bmp4 stimulation E Cagavi, O Bartulos, CY Suh, B Sun, Z Yue, Z Jiang, L Yue, Y Qyang PloS one 9 (12), e110752, 2014 | 38 | 2014 |
| ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarction O Bartulos, ZW Zhuang, Y Huang, N Mikush, C Suh, A Bregasi, L Wang, ... JCI insight 1 (10), 2016 | 33 | 2016 |
| Tyrosine hydroxylase is expressed during early heart development and is required for cardiac chamber formation C Lopez-Sanchez, O Bartulos, E Martínez-Campos, C Ganan, ... Cardiovascular research 88 (1), 111-120, 2010 | 31 | 2010 |
| The regulated expression of chimeric tyrosine hydroxylase–insulin transcripts during early development C Hernandez-Sanchez, O Bartulos, AI Valenciano, A Mansilla, F de Pablo Nucleic acids research 34 (12), 3455-3464, 2006 | 16 | 2006 |
| Proinsulin: much more than a hormone precursor in development C Hernández-Sánchez, Ó Bártulos, F Pablo Reviews in Endocrine and Metabolic Disorders 6, 211-216, 2005 | 8 | 2005 |
| Advancements in induced pluripotent stem cell technology for cardiac regenerative medicine CY Suh, Z Wang, O Bártulos, Y Qyang Journal of cardiovascular pharmacology and therapeutics 19 (4), 330-339, 2014 | 7 | 2014 |
| Controlled, large-scale manufacturing of hiPSC-derived cardiomyocytes in stirred-tank bioreactors Y Jiang, K Langenberg, V Borgdorff, M Duńska, R Post, O Bartulos, ... | 4 | 2023 |
| Contraction pressure analysis using optical imaging in normal and MYBPC3-mutated hiPSC-derived cardiomyocytes grown on matrices with tunable stiffness M Snelders, IH Koedijk, J Schirmer, O Mulleners, J van Leeuwen, ... Biomaterials and Biosystems 8, 100068, 2022 | 1 | 2022 |
| Contraction Force Analysis Using Optical Imaging in Normal and Mybpc3-Mutated iPSC-Derived Cardiomyocytes Grown on Matrices With Tunable Stiffness J Hofmann, O Mulleners, T Noordermeer, J van Leeuwen, O Bartulos, ... Circulation 138 (Suppl_1), A15646-A15646, 2018 | | 2018 |
| Journal of Heart Health O Bartulos | | 2015 |
| Application of iPS Cell Technology for Cardiac Disease Modeling and Repair A Sivarapatna, O Bartulos, CY Suh, Y Qyang J Clinic Experiment Cardiol 3, e105, 2012 | | 2012 |
| Uso de catecolamina para la diferenciación de células madre a cardiomiocitos. F Pablo, Ó Bártulos Encinas, C Hernández-Sánchez, A Aranega Jiménez | | 2011 |
| Use of catecholamine for differentiation of stem cells into cardiomyocytes C Hernández-Sánchez, Ó Bártulos Encinas, F Pablo, A Aranega Jiménez | | 2010 |
